Lataa...
Assessment of tumor oxygenation and its impact on treatment response in bevacizumab-treated recurrent glioblastoma
Antiantiogenic therapy with bevacizumab in recurrent glioblastoma is currently understood to both reduce microvascular density and to prune abnormal tumor microvessels. Microvascular pruning and the resulting vascular normalization are hypothesized to reduce tumor hypoxia and increase supply of syst...
Tallennettuna:
| Julkaisussa: | J Cereb Blood Flow Metab |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381446/ https://ncbi.nlm.nih.gov/pubmed/26861817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0271678X16630322 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|